Artemisinin is an anti-malaria medication with no side-effects that has activity against 115 kinds of cancer in vitro.

It comes from Sweet Wormwood (Artemisia annua), a traditionally Chinese plant that, thanks to ArtemiFlow, can now be produced at low cost and at large scale in the U.S.

ArtemiFlow companies offer solutions that deliver controlled doses of artemisinin through a range of products for humans and pets designed to be integrated into daily life. 

Currently in clinical trials for prostate and ovarian cancer, ArtemiFlow aims to produce the first over-the-counter cancer medication with efficacy against cancer recurrence.